Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset

American Journal of Neuroradiology

Volumn 20, Issue 6, 1999, Pages 965-976

  Jordan, E Kay ^b   McFarland, Hugh I ^b   Lewis, Bobbi K ^b   Tresser, Nancy ^b   Gates, Michael A ^b   Johnson, Michele ^b   Lenardo, Michael ^b   Matis, Louis A ^b   McFarland, Henry F ^b   Frank, Joseph A ^a  

^a LDRR   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; FREUND ADJUVANT; GADOLINIUM PENTETATE; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATION; FEMALE; HISTOPATHOLOGY; MALE; MARMOSET; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SYMPTOMATOLOGY; WHITE MATTER;

ANIMALS; BRAIN; BRAIN TISSUE TRANSPLANTATION; CALLITHRIX; CHILD; CHILD, PRESCHOOL; CHIMERA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; RECOMBINANT FUSION PROTEINS; SPINAL CORD;

EID: 0032699588     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995;32:121-182
2. Martin R, McFarland H. Experimental immunotherapies for multiple sclerosis. Springer Semin Immunopathol 1996;18:1-24
3. McFarland HI, Critchfield JM, Racke MK, et al. Amelioration of autoimmune reactions by antigen-induced apoptosis of T cells. Adv Exp Med Biol 1995;383:157-166
4. Racke MK, Critchfield JM, Quigley L, et al. Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann Neurol 1996;39:46-56
5. Calabresi PA, Stone LA, Bash CN, Frank JA, McFarland HF. Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MR. Neurology 1997;48:1446-1448
6. William PP. The epidemiology of multiple sclerosis. In: Cook SD, ed. The Handbook of Multiple Sclerosis New York, NY: Marcel Dekker, Inc; 1996:1-17
7. Prineas JW. Pathology of multiple sclerosis. In: Cook SD, ed. The Handbook of Multiple Sclerosis. New York, NY: Marcel Dekker, Inc; 1996;223-256
8. Thompson AJ, Dermode AG, MacManus DG, et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ 1990;300:631-634
9. Lai M, Hodgson T, Gawne-Cain, et al. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1966;60:339-341
10. Gonzalez-Scarano F, Grossman RI, Galetta S, Atlas SW, Silberberg DH. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Ann Neurol 1987;21:300-306
11. Isaac C, Li DKB, Genton M, et al. Multiple Sclerosis: a serial study using MRI in relapsing patients. Neurology 1988;38: 1511-1515
12. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927-939
13. McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992;32:758-766
14. Miller DH, Barkhof F, Nauta JJP. Gadolinium enhancement increases the sensitivity of MR in detecting disease activity in multiple sclerosis. Brain 1993;116:1077-1094
15. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993;33:480-489
16. Frank JA, Stone LA, Smith ME, Albert PS, Maloni H, McFarland HF. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials. Ann Neurol 1994;36 (Suppl): S86-S90
17. Stone LA, Smith ME, Albert PS, et al. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 1995;45:1122-1126
18. Stone LA, Albert PS, Smith ME, et al. Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology 1995;45:1808-1814
19. Miller DH, Albert PS, Barkhof F. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16
20. Frank JA, Bash C, Stone L, Petrella J, Maloni H, McFarland H. Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. Acad Radiol 1996;3:S173-S175
21. Raine CS. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984; 50:608-635
22. Paterson PY. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 1960;111:119-135
23. Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2-T lymphocytes. J Immunol 1981;127:1420-1423
24. Alvord EC, Driscoll BF, Kies MW. Large subpial plaques of demyelination in a new form of chronic experimental allergic encephalomyelitis in the guinea pig. Neurochem Pathology 1985;3:195-214
25. Bouwer HG, Hinrichs DJ. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes. J Neuroimmunol 1994;54:87-98
26. Swanbord RH. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 1995;77:4-13
27. Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann Neurol 1995;37:519-530
28. Benirschke K, Anderson JM, Brownhill LE. Marrow chimerism in marmosets. Science 1962;138:-513
29. Benirschke K, Brownhill LE. Further observations on marrow chimerism in marmosets. Cytogenetics 1962;1:-245
30. Rose LM, Richard TL, Peterson J, Peterson R, Alvord EC. Resolution of CNS lesions following treatment of experimental allergic encephalomyelitis in macaques with monoclonal antibody to the CD18 leukocyte integrin. Mult Scler 1997;2: 259-266
31. Xu S, Jordan EK, Li W, et al. In vivo three-dimensional MR microscopy of mice with chronic relapsing experimental autoimmune encephalomyelitis after treatment with insulin-like growth factor-I. AJNR Am J Neuroradiol 1998;19:653-658
32. Kent SJ, Karlik SJ, Rice GP, Horner HC. A monoclonal antibody to α4-integrin reverses the MR-detectable signs of experimental allergic encephalomyelitis in the guinea pig. J Magn Reson 1995;5:535-540
33. van Lambalgen R, Jonker M. Experimental allergic encephalomyelitis in rhesus monkeys. II. Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies. Clin Exp Immunol 1987;67:305-312
34. Morrissey SP, Deichmann R, Syha J, et al. Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies. J Neuroimmunol 1996;69:85-93
35. Karlik SJ, Wong C, Gilbert JJ, Noseworthy JH. NMR studies in the relapsing experimental allergic encephalomyelitis (EAE) model of multiple sclerosis in the strain 13 guinea pig. Magn Reson Imaging 1989;7:463-473
36. Zamaroczy D, Hermann J, Schluesener, et al. Differentiation of Experimental white matter lesions using multiparametric magnetic resonance measurements. Invest Radiol 1991;26: 317-324
37. Namer IJ, Steibel J, Poulet P, Armspach JP, Mauss Y, Chambron J, In vivo dynamic MR imaging of MBP-induced acute experimental allergic encephalomyelitis in Lewis Rat. Magn Reson Med 1992;24:325-334
38. Heide AC, Richards TL, Alvord Jr EC, Peterson J, Rose LM. Diffusion imaging of experimental allergic encephalomyelitis. Magn Reson Med 1993;29:178-484
39. Seeldrayers PA, Syha J, Morrissey SP. Magnetic resonance imaging investigation of blood-brain barrier damage in adoptive transfer experimental autoimmune encephalomyelitis. J Neuroimmunol 1993;46:199-206
40. Lanens D, Van der Linden A, Gerrits PO, Gravenmade EJ. In vitro NMR micro imaging of the spinal cord of chronic relapsing EAE rats. Magn Reson Imaging 1994;12:469-475
41. Morrissey SP, Stodal H, Zettl U, et al. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 1996;119:239-248
42. Duckers HJ, Muller HJ, Verhaagen J, Nicolay K, Gispen WH. Longitudinal in vivo magnetic resonance imaging studies in experimental allergic encephalomyelitis: effect of a neurotrophic treatment on cortical lesion development. Neuroscience 1997;77:1163-1173
43. Xu S, Jordan EK, Brocke S, et al. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: early histopathological correlation. J Neurosci Res 1998;52:549-558
44. Grossman RI, Lisak RP, Macchi PJ, Joseph PM. MR of acute experimental allergic encephalomyelitis. AJNR Am J Neuroradiol 1987;8:1045-1048
45. Kuharik MA, Edwards MK, Farlow MR, et al. Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions. ANJR Am J Neuroradiol 1988;9:643-648
46. Namer IJ, Steibel J, Poulet P, et al. Blood-brain barrier break-down in MBP-specific T cell induced experimental allergic encephalomyelitis. Brain 1993;116:147-159
47. Karlik SJ, Grant EA, Lee D, Noseworthy JH. Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig. Magn Reson Med 1993;30:326-331
48. Namer IJ, Steibel J, Piddlesden SJ, Mohr M, Poulet P, Chambron J. Magnetic resonance imaging of antibody-mediated demyelinating experimental allergic encephalomyelitis. J Neuroimmunol 1994;54:41-50
49. Dousset V. Magnetization transfer imaging in vivo study of normal brain tissues and characterization of multiple sclerosis and experimental allergic encephalomyelitis lesions. J Neuroradiol 1993;20:297-298
50. Hawkins CP, Numro PMG, MacKenzie MF, et al. Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990;113: 365-378
51. Hawkins CP, Mackenzie F, Tofts P, Du Boulay EPGH, McDonald WI. Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain 1991;114:801-810
52. Stewart WA, Alvord EC, Hruby S, Hall LD, Paty DW. Early detection of experimental allergic encephalomyelitis by magnetic resonance imaging. Lancet 1985;19:-898
53. Stewart WA, Alvord Jr EC, Hruby S, Hall LD, Paty DW. Magnetic resonance imaging of experimental allergic encephalomyelitis in primates. Brain 1991;114:1069-1096
54. Richard TL, Alvord EC, He Y, et al. Experimental allergic encephalomyelitis in non-human primates: diffusion imaging of acute and chronic brain lesions. Mult Scler 1995;1:109-117
55. Richards TL, Alvord EC, Peterson J, et al. Experimental Allergic Encephalomyelitis in non-human primates: MRI and MRS may predict the type of brain damage. NMR in Biomed 1995; 8:49-58
56. Genain CP, Lee-Parritz D, Nguyen M-H, et al. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest 1994;94:1339-1345
57. Genain CP, Nguyen M-H, Letvin NL, et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995;96:2966-2974
58. Genain CP, Abel K, Belmar N, et al. Late complications of immune deviation therapy in a nonhuman primate. Science 1996; 274:2054-2057
59. Hart BA, Bauer J, Muller H-J, Melchers B, et al. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis. A correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). Am J Pathol 1998:153;649-663
60. Nye SH, Pelfrey CM, Burkwit JJ, Voskuhl RR, Lenardo MJ, Mueller JP. Purification of immunologically active recombinant 21.5 kDa isoform of human myelin basic protein. Mol Immunol 1995;32:1131-1141
61. Elliot EA, McFarland HI, Nye SH, et al. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest 1996;98:1602-1612
62. Shaw CM, Alvord EC. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis. In: Alvord EC, Kies MW, Suckling AJ, eds. Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis New York, NY: Alan R. Liss Inc; 1984:61-65
63. Alvord EC. EAE and MS. 1984. In Experimental Allergic Encephalomyelitis. In: Alvord EC, Kies MW, Suckling AJ, eds. Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis. New York, NY: Alan R. Liss Inc; 1984:504-508
64. Kibler RF, Re' PK, McKneally S, Shapira R, Keeling ME. Biological activity of an encephalitogenic fragment in the monkey. J Biol Chem 1972;2:969-972
65. Alvord EC, Shaw C-M, Hruby S. Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys. Ann Neurol 1979;6:469-473
66. Shaw C-M, Ellsworth C, Alvord Jr, Hruby S. Chronic remitting-relapsing experimental allergic encephalomyelitis induced in monkeys with homologous myelin basic protein. Ann Neurol 1988;24:738-748
67. Massacesi L, Joshi N, Lee-Paritz D, Rombos A, Letvin NL, Hauser SL. Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood. J Clin Invest 1992;90:399-404
68. Lorentzen JC, Issazadeh S, Storch M, et al. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J Neuroimmunol 1995;63: 193-205
69. Rivers TM, Schwentder FF. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 1935;61:689-702
70. Ravkina L, Rogova V, Lazarenko L. Chronic experimental allergic encephalomyelitis in rhesus monkeys and its modification by treatment. J Neurol Sci 1978;38:281-293
71. Rose LM, Richard T, Alvord EC. Experimental allergic encephalomyelitis (EAE) in nonhuman primates: a model of multiple sclerosis. Lab Anim Sci 1994;44:508-512
72. van Walderveen MA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995;45:1684-1690
73. Truyen L, van Waesberghe JH, van Walderveen MA, et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476
74. Stephan H, Baron G, Schwerdtfeger WK. The Brain of the Common Marmoset (Callithrix jacchus). A Stereotaxic Atlas. Berlin, Heidelberg: Springer-Verlag; 1980:1-4
75. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993;72: 551-560
76. Filippi M, Horsfield MA, Campi A, Mammi S, Pereira C, Comi G. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38:749-754
77. Filippi M, Yousry T, Horsfield MA, et al. A high-resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 1996;40:901-907